NEW YORK, Sept. 23, 2026 /PRNewswire/ — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Fractyl Health, Inc. (NASDAQ: GUTS) breached their fiduciary duties to shareholders.
According to a federal securities lawsuit, Fractyl Health misrepresented or failed to disclose (i) Revita, an outpatient therapy designed to modify duodenal dysfunction, was less effective than the Company had led investors to believe, and/or operational issues at one or more of its efficacy clinical study sites compromised the integrity of its efficacy results; and (ii) accordingly, Revita’s clinical, regulatory, and commercial prospects were overstated, as was its efficacy study’s ability to assess Revita’s efficacy.
If you currently own GUTS and purchased prior to January 13, 2025 please contact Sophia Anne Silayan, by email at sophiaanne@kuehn.law or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
For additional information, please visit Shareholder Derivative Litigation – Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-fractyl-health-inc-to-contact-law-firm-302888184.html
SOURCE Kuehn Law, PLLC
